Codexis
Codexis, Inc. is an industrial biotechnology company that specializes in the discovery, development, and commercialization of protein catalysts for pharmaceutical and chemical production through biocatalysis. Founded in 2002 and headquartered in Redwood City, California, Codexis utilizes its proprietary CodeEvolver directed evolution technology platform to create enzyme optimization solutions that enhance process development from research to manufacturing. The company offers a range of products and services, including biocatalysts, enzyme screening, and protein engineering services, which are utilized by over 50 pharmaceutical firms globally. Codexis generates the majority of its revenue through product sales and also licenses its CodeEvolver technology to enable pharmaceutical companies to engineer enzymes for their own production needs. Its customer base spans various markets, including the United States, Europe, and Asia, contributing to the company's growth in the biotechnology sector.
Top Stages
3 past transactions
seqWell
Series C in 2022
seqWell Inc. is a biotechnology company based in Beverly, Massachusetts, specializing in sequencing services and library preparation workflows. Founded in 2014, seqWell offers a range of products, including paramagnetic beads for nucleic acid purification and library preparation kits. The company has developed a transformative technology platform that enables simple and scalable multiplexing of hundreds to thousands of samples, significantly reducing the time and costs associated with normalization. In addition to its products, seqWell provides comprehensive biological library preparation, sequencing, data processing, and customized bioinformatics support services. Its offerings are distributed in various countries, including the United States, Australia, South Korea, and several European nations, as well as through online channels.
Molecular Assemblies
Series B in 2022
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
Molecular Assemblies
Series A in 2021
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, aimed at creating DNA-based products across various industries. Founded in 2013, the company has developed a proprietary method that allows for the reliable, affordable, and sustainable production of long, high-quality, sequence-specific DNA. This innovative technology is designed to support advancements in industrial synthetic biology, personalized therapeutics, precision diagnostics, and has potential applications in information storage and nanotechnology. With a strong executive and scientific team, as well as a robust intellectual property portfolio, Molecular Assemblies is positioned to enhance the capabilities of researchers and contribute to the evolution of DNA-based applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.